SEP 14·SEC EDGARLow
DIVITA CHARLES III sold $109K of TDOC
DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 17,805 shares of Teladoc Health, Inc. (TDOC) at $6.10 ($0.11M total) on 2026-09-11.
StockNYSE · US · USDHealthcare · Health Information Services
$TDOC
Teladoc Health, Inc.
AlphAI earnings readSecond Quarter 2026 · JUL 29Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year; net loss of $38.9 million, or $0.21 per share; and adjusted EBITDA of $65.7 million, down 5% year-over-year.Verdict: mixedRead →
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Price · $TDOCvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $TDOC in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $457K 8 txs
Rodrigues Fernando M.2× · $98K
10b5-1 share of filings25%
Top stories · $TDOCMore →
SEP 8·fool.com
2 Beaten-Down Stocks to Avoid Right Now
Teladoc Health (TDOC) and Recursion Pharmaceuticals (RXRX) face significant challenges. Teladoc's revenue declined 4% YoY to $606.9M, with BetterHelp's revenue and users dropping 12% and 11% YoY, respectively. Recursion, an AI-driven biotech, lacks approved products and has seen its stock fall 21% over the past year. Both companies show dim prospects, according to the analysis.
SEP 7·tradingview.com
Here's Why Teladoc's Integrated Care Business Deserves More Attention
Teladoc Health's (TDOC) Integrated Care segment is driving profitability, generating $394.3M in Q2 revenue and $65.2M in adjusted EBITDA. The segment's focus on chronic care and enterprise contracts positions it for growth, while Teladoc One, launching in 2027, could further boost earnings. TDOC shares have gained 18.5% over six months, trading at a forward P/S ratio of 0.47X.
TDOC sentiment & insider activity
Recent TDOC coverage spans financial news, corporate actions and insider activity.
In the last 30 days, TDOC insiders filed 8 SEC Form 4 transactions — no purchases and 8 sales ($457K). The most active reporter was Rodrigues Fernando M., President of BetterHelp, with 2 filings. 25% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving TDOC
Minor insider sell by CEO; unlikely to move price materially.
Quarterly results confirm ongoing challenges; no immediate catalyst for price rebound.
Integrated Care now drives most of Teladoc's earnings, suggesting a shift in growth narrative away from BetterHelp.
Compensation grant may signal confidence in new CFO and could modestly affect share perception.
Minor dilution of insider ownership; unlikely to move the stock materially.
AlphAI scores every news story that mentions TDOC with an AI model for sentiment and relevance, and aggregates insider trades from Teladoc Health, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $TDOC
Score
DIVITA CHARLES III sold $109K of TDOC
DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 17,805 shares of Teladoc Health, Inc. (TDOC) at $6.10 ($0.11M total) on 2026-09-11.
1 min read
2 Beaten-Down Stocks to Avoid Right Now
Teladoc Health (TDOC) and Recursion Pharmaceuticals (RXRX) face significant challenges. Teladoc's revenue declined 4% YoY to $606.9M, with BetterHelp's revenue and users dropping 12% and 11% YoY, respectively. Recursion, an AI-driven biotech, lacks approved products and has seen its stock fall 21% over the past year. Both companies show dim prospects, according to the analysis.
2 min read
Here's Why Teladoc's Integrated Care Business Deserves More Attention
Teladoc Health's (TDOC) Integrated Care segment is driving profitability, generating $394.3M in Q2 revenue and $65.2M in adjusted EBITDA. The segment's focus on chronic care and enterprise contracts positions it for growth, while Teladoc One, launching in 2027, could further boost earnings. TDOC shares have gained 18.5% over six months, trading at a forward P/S ratio of 0.47X.
2 min read
Teladoc Health announces employee inducement awards
Teladoc Health granted new CFO Michael Grasher 239,616 restricted stock units and performance stock units, with vesting tied to service and financial targets. The performance stock units are linked to 2026 EBITDA and 2026-2028 revenue growth.
1 min readDIVITA CHARLES III sold $115K of TDOC
DIVITA CHARLES III (CHIEF EXECUTIVE OFFICER) sold 18,327 shares of Teladoc Health, Inc. (TDOC) at $6.30 ($0.12M total) on 2026-09-02.
1 min readTeladoc Health, Inc. (TDOC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Teladoc Health Appoints Michael Grasher as Chief Financial Officer Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, August 31, 2026 — Teladoc Health, Inc. (NYSE: TDO
1 min readTeladoc appoints insurance executive Michael Grasher as CFO
Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.
2 min readTeladoc Health Appoints Michael Grasher As Chief Financial Officer; Stock Down
Teladoc Health (TDOC) appointed Michael Grasher as CFO. Grasher has 30+ years of experience in finance, most recently at IFG Companies. TDOC stock is down 4.70% to $6.18, trading between $4.40 and $9.89 over the past year.
1 min readTeladoc Health, Inc. (TDOC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the “Company”) of his intention to retire from th
2 min readTeladoc Health (TDOC) Could Be 55% Undervalued On Board Change And 2026 Guidance
Simply Wall St says Teladoc Health (TDOC) appointed Mark V. Anquillare to its board and updated 2026 guidance after recent quarterly results. The stock last traded at $6.81, down 26.62% over 30 days and 95.10% over five years. The article cites a $15.00 fair value estimate and discusses cash flow and BetterHelp’s insurance shift.
7 min read